85846-80-6

Basic information

• Product Name: (3aR,6R,6aR)-6-(benzyloxyMethyl)-2,2-diMethyldihydrofuro[3,4-d][1,3]dioxol-4(3aH)-one
• Synonyms: (3aR,6R,6aR)-6-(benzyloxyMethyl)-2,2-diMethyldihydrofuro[3,4-d][1,3]dioxol-4(3aH)-one;5-O-Benzyl-2,3-O-ispropylidene-D-ribono-1,4-lactone
• CAS NO: 85846-80-6
• Molecular Formula: C₁₅H₁₈O₅
• Molecular Weight: 278.30042
• Mol File: 85846-80-6.mol
• Article Data: 14

Chemical Properties

• Boiling Point: 125-135 °C(Press: 1e-05 Torr)
• Appearance: /
• Density: 1.181±0.06 g/cm3(Predicted)
• CAS DataBase Reference: (3aR,6R,6aR)-6-(benzyloxyMethyl)-2,2-diMethyldihydrofuro[3,4-d][1,3]dioxol-4(3aH)-one(CAS DataBase Reference)
• NIST Chemistry Reference: (3aR,6R,6aR)-6-(benzyloxyMethyl)-2,2-diMethyldihydrofuro[3,4-d][1,3]dioxol-4(3aH)-one(85846-80-6)
• EPA Substance Registry System: (3aR,6R,6aR)-6-(benzyloxyMethyl)-2,2-diMethyldihydrofuro[3,4-d][1,3]dioxol-4(3aH)-one(85846-80-6)

Safety Data

• Hazardous Substances Data: 85846-80-6(Hazardous Substances Data)

Usage

General Description

The chemical "(3aR,6R,6aR)-6-(benzyloxyMjson: 00012132&isoName=-)-2,2-diMethyldihydrofuro[3,4-d][1,3]dioxol-4(3aH)-one" is a compound with a complex molecular structure. It is a dihydropyran derivative with a benzyloxyMethyl group attached to one of its carbon atoms. The compound also contains two methyl groups and a dioxolane ring. It may be used in organic synthesis as a reagent or intermediate for the preparation of other compounds. Its precise uses and properties will depend on the specific application and the context in which it is used.

Upstream product

• 100-39-0 benzyl bromide 
• 78508-91-5 5-benzyloxy-2-hydroxy-3-hydroxy-D-ribonolactone 
• 77-76-9 2,2-dimethoxy-propane 
• 30725-00-9 2,3-O-isopropylidene-D-ribonic-γ-lactone 
• 92512-33-9 (3R,4S,5R)-5-((tert-butyldiphenylsilyloxy)methyl)-3,4-dihydroxydihydrofuran-2(3H)-one 
• 157453-65-1 (3R,4S,5R)-5-(tert-butyldimethylsilyloxymethyl)-3,4-dihydroxy-dihydrofuran-2-one 
• 93-99-2 benzoic acid phenyl ester 
• 5336-08-3 D-Ribono-1,4-lactone 
• 81927-55-1 O-benzyl 2,2,2-trichloroacetimidate 

Downstream Products

• 117251-95-3 Dimethyl (6-O-benzyl-3,4-O-isopropylidene-α-D-ribo-2-hexulofuranosyl)phosphonate 
• 30725-00-9 2,3-O-isopropylidene-D-ribonic-γ-lactone 
• 198969-39-0 5-O-benzyl-2,3-O-isopropylidene-D-ribofuranose 
• 106839-88-7 2-Benzyloxy-1-((4R,5S)-5-hydroxymethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-ethanol 
• 117251-95-3 Dimethyl (6-O-benzyl-1-deoxy-3,4-O-isopropylidene-β-D-ribo-hex-2-ulofuranosyl)phosphonate 
• 582313-73-3 2-(6-benzyloxymethyl-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)propionic acide ethyl ester 
• 89291-74-7 (3R,4R)-(-)-6-O-benzyl-1-deoxy-1-(dimethylphosphono)-3,4-O-isopropylidene-D-erythro-2,5-hexodiulose 
• 89291-71-4 (3R,4R)-(-)-6-O-benzyl-1-deoxy-1-(dimethylphosphono)-3,4-O-isopropylidene-D-ribo-hexulose 
• 97204-83-6 (1R)-(+)-1-[(4R,5S)-2,2-dimethyl-5-vinyl-1,3-dioxolan-4-yl]-2-(benzyloxy)ethan-1-ol 
• 257281-18-8 (3aS,4R,8aS)-4-Benzyloxymethyl-2,2-dimethyl-3a,4,6,8a-tetrahydro-[1,3]dioxolo[4,5-c]oxepine 
• 257281-17-7 (4S,5S)-4-((R)-1-Allyloxy-2-benzyloxy-ethyl)-2,2-dimethyl-5-vinyl-[1,3]dioxolane 
• 257281-19-9 (3aR,4R,7R,8R,8aS)-4-Benzyloxymethyl-2,2-dimethyl-hexahydro-[1,3]dioxolo[4,5-c]oxepine-7,8-diol 
• 1224588-03-7 (3aR,6R,6aR)-6-benzyloxymethyl-2,2-dimethyl-4-(2-methoxyphenyl)tetrahydrofuro[3,4-d][1,3]dioxol-4-ol 
• 5336-08-3 D-Ribono-1,4-lactone 

Relevant articles and documents

Highly regioselective and stereoselective synthesis of C-Aryl glycosidesvianickel-catalyzedortho-C-H glycosylation of 8-aminoquinoline benzamides

C-Aryl glycosides are of high value as drug candidates. Here a novel and cost-effective nickel catalyzedortho-CAr-H glycosylation reaction with high regioselectivity and excellent α-selectivity is described. This method shows great functional group compatibility with various glycosides, showing its synthetic potential. Mechanistic studies indicate that C-H activation could be the rate-determining step.

NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO

This disclosure relates to nucleotide and nucleoside therapeutic compositions and uses in treating infectious diseases, viral infections, and cancer, where the base of the nucleotide or nucleoside contains at least one thiol, thione or thioether.

Ophthamological drugs

The present invention relates generally to ophthamological drugs. More specifically, the inventon relates to a method of modifying (derivatizing) ophthamological drugs so as to increase their penetration through the cornea. The invention also relates to d